These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2606936)

  • 1. Nicotine and estrogen metabolism--possible implications of smoking for growth and outcome of treatment of hormone-dependent cancer? Discussion of experimental results.
    Zeller WJ; Berger MR
    J Cancer Res Clin Oncol; 1989; 115(6):601-3. PubMed ID: 2606936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice.
    Iino Y; Takai Y; Ando T; Sugamata N; Maemura M; Takeo T; Ohwada S; Morishita Y
    Cancer Chemother Pharmacol; 1993; 32(5):353-8. PubMed ID: 8339385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.
    Barbieri RL; Gochberg J; Ryan KJ
    J Clin Invest; 1986 Jun; 77(6):1727-33. PubMed ID: 3711333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer and its hormonal dependency].
    Matsumoto K; Sato B
    Gan No Rinsho; 1989 May; Spec No():204-11. PubMed ID: 2689662
    [No Abstract]   [Full Text] [Related]  

  • 6. [1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action I: antitumor activity due to the reduction of the endogenous estrogen level.
    Schertl S; Hartmann RW; Batzl-Hartmann C; Bernhardt G; Spruss T; Beckenlehner K; Koch M; Krauser R; Schlemmer R; Gust R; Schönenberger H
    Arch Pharm (Weinheim); 2004 Jun; 337(6):335-48. PubMed ID: 15188223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nicotine with anticancer treatment.
    Berger MR; Zeller WJ
    Klin Wochenschr; 1988; 66 Suppl 11():127-33. PubMed ID: 3184771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
    Briand P
    Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G; Heuson JC
    Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.
    Szepeshazi K; Schally AV; Halmos G; Groot K; Radulovic S
    J Natl Cancer Inst; 1992 Dec; 84(24):1915-22. PubMed ID: 1460673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
    Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL
    Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reassessment of the role of breast tumor aromatization.
    Bradlow HL
    Cancer Res; 1982 Aug; 42(8 Suppl):3382s-3386s. PubMed ID: 7083204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hydroxysteroid (17-beta) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts.
    Husen B; Huhtinen K; Saloniemi T; Messinger J; Thole HH; Poutanen M
    Endocrinology; 2006 Nov; 147(11):5333-9. PubMed ID: 16916945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors: rationale for use following antiestrogen therapy.
    Yue W; Santen RJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone dependence in premalignant mammary progression.
    Medina D; Kittrell FS; Shepard A; Contreras A; Rosen JM; Lydon J
    Cancer Res; 2003 Mar; 63(5):1067-72. PubMed ID: 12615724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
    Kuramoto M; Yamashita J; Ogawa M
    Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in hormone-dependent (responsive) and autonomous mammary tumor growth: role of autostimulatory growth factors.
    Danielpour D; Sirbasku DA
    In Vitro; 1984 Dec; 20(12):975-80. PubMed ID: 6530229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.